Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of November 2025. The filing, dated November 13, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The company is headquartered in Paris, France, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement containing quantitative data.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. The content is limited to the procedural incorporation of an external press release.
Guidance, Outlook, and Risks
Specific details regarding guidance, outlook, management commentary, risks, contingencies, or unusual items are not present in the provided text. These details are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the input content.
Key Facts for Investor Verification
- Verify the content of the press release dated November 13, 2025, attached as Exhibit 99.1, as the filing itself contains no operational or financial data.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.